Catalent Inc (NYSE:CTLT)
$ 63.48 0 (0%) Market Cap: 11.52 Bil Enterprise Value: 16.13 Bil PE Ratio: 0 PB Ratio: 3.25 GF Score: 80/100

Catalent Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 10, 2022 / 12:30PM GMT
Release Date Price: $118.31 (+2.47%)
Tycho W. Peterson
JPMorgan Chase & Co, Research Division - Senior Analyst

All right. Good morning, everybody. Welcome to the 2022 Healthcare Conference. I'm pleased to introduce our first company this morning, Catalent.

Before I turn it over to John, just a quick reminder, there's a Submit Question feature on the website for people that want questions answered. So with that, let me turn it over to John.

John R. Chiminski
Catalent, Inc. - Chairman & CEO

Well, hello, everyone. Good morning. I'm very proud to represent Catalent today and share with you our growth story, enhanced by our ESG journey.

Before diving into the presentation, let me first draw your attention to Slides 2 and 3, which note our cautions regarding our use today forward-looking statements and non-GAAP financials. I also encourage you to review our SEC filings to understand the risks and uncertainties that may bear on our operating results and financial condition.

So now turning to the presentation on Slide 4. Catalent is a purpose-driven service company,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot